persist
infect
human
coronaviru
establish
human
continu
cell
line
l
follow
initi
infect
stock
sever
cultur
establish
two
hv
maintain
contin
passag
two
year
eultur
shed
high
titr
infecti
viru
continu
supernat
fluid
sinc
initi
persist
infect
ceil
resist
homolog
superinfect
support
polio
viru
replic
normal
titr
preliminari
test
indic
percent
cell
contain
viru
neither
interferon
revers
transeriptas
could
detect
cultur
presenc
defect
interf
particl
could
demonstr
vh
v
h
coronavirus
isol
persist
infect
cultur
hv
identifi
antiserum
neutral
eytoeid
parent
viru
judg
plaqu
characterist
cpe
howev
indistinguish
basi
densiti
em
morpholog
genom
size
present
evid
indic
temperatur
play
import
yet
undetermin
role
establish
mainten
stabl
e
persist
infect
cell
cultur
coronavirus
import
pathogen
human
anim
caus
varieti
respiratori
enter
infect
worldwid
distribut
addit
well
known
acut
infect
man
swine
dog
eat
calv
chicken
long
term
eoronavir
infect
describ
chicken
mice
swine
also
report
human
eoronaviru
hcv
caus
mild
upper
respiratori
infect
isol
nasal
wash
human
day
human
enter
coronaviru
hecv
isol
gillian
ciialonerlabsson
c
margaret
johnsonlussenburg
faec
sever
month
thu
seem
evid
h
closer
e
n
n
given
exist
chronic
n
p
p
r
e
n
eoronavir
infect
human
increasingli
interest
focuss
h
u
n
coronaviru
suggest
n
v
l
v
e
e
n
persist
infect
balkan
endem
nephropathi
possibl
etiolog
role
multipl
sclerosi
ms
inabl
tempor
assay
h
u
n
tissu
hcv
hecv
acut
infect
made
investig
persist
h
u
n
coronaviru
infect
difficult
difficulti
compound
coronavirus
notori
fastidi
host
rang
usual
restrict
n
u
r
l
host
suitabl
h
u
n
coronaviru
model
vitro
persist
infect
report
date
hand
vivo
n
vitro
persist
chronic
infect
mous
cell
strain
mous
hepat
viru
r
n
e
eoronaviru
well
document
n
absenc
suitabl
h
u
n
host
eoronavirn
model
murin
system
propos
suitabl
model
u
h
u
n
diseas
paper
describ
sueces
establish
vitro
persist
infect
h
u
n
cell
line
h
u
n
eoronaviru
strain
date
n
n
e
h
n
passag
period
month
continu
shed
high
titr
infecti
viru
system
great
potenti
studi
viru
replic
pathogenesi
eoronavim
diseas
eoronaviru
genet
cell
cell
cultur
iiuman
fetal
lung
cell
l
continu
cell
line
support
human
coronaviru
replic
use
throughout
routin
propag
describ
previous
use
eagl
minim
essenti
medium
flow
laboratori
inc
mississauga
ontario
canada
supplement
percent
fetal
bovin
serum
fb
flow
lab
inc
sodium
bicarbon
mr
penicillin
uml
streptomycin
ugml
neomycin
pgml
glutamin
mf
c
ceil
passag
everi
two
day
split
ratio
iiuman
eoronaviru
strain
use
experi
stock
viru
grown
l
cell
maintain
laboratori
polioviru
type
sabin
strain
use
superinfeet
studi
obtain
dr
sattar
depart
normal
cell
ii
standard
viru
v
persist
infect
cell
iiv
viru
deriv
persist
infect
cell
l
v
growth
viru
l
monolay
infect
multipl
pfucel
follow
adsorpt
period
hour
room
temperatur
incub
ar
hour
medium
flow
lab
inc
without
serum
supplement
glutamin
antibiot
per
cent
sodium
bicarbon
infect
cultur
subjee
three
freezethaw
cycl
store
aliquot
c
use
viru
inoculum
requir
titr
stock
viru
pfuml
f
r
h
e
p
r
e
p
r
n
radioisotop
label
viru
h
e
cell
infect
h
e
end
h
e
r
p
n
period
either
uridin
ciml
specif
c
v
cirnmol
acid
x
u
r
e
ciml
includ
n
e
n
n
c
e
e
u
r
c
h
e
c
l
n
e
w
e
n
g
l
n
nuclear
step
carri
u
c
follow
h
r
e
e
freezethaw
cycl
releas
viru
e
n
f
e
c
e
cell
lysat
clarifi
b
two
cycl
centrifug
first
low
speed
e
c
p
r
j
r
p
minut
n
h
e
n
e
n
speed
e
c
b
g
minut
h
e
viru
h
e
n
cushion
onto
ml
p
e
r
c
e
n
wv
sucros
p
h
p
h
e
buffer
p
b
e
c
k
n
rotor
r
p
g
minut
c
n
c
e
n
r
e
viru
collect
h
e
interfac
n
pellet
b
e
c
k
n
f
rotor
r
p
g
hour
h
e
pellet
resuspend
u
p
h
p
h
e
buffer
pii
overlaid
onto
linear
p
e
r
c
e
n
ww
sucros
g
r
e
n
sodium
p
h
p
h
e
n
centrifug
e
q
u
l
b
r
u
b
e
c
k
n
rotor
r
p
hour
fraction
collect
n
sampl
zl
c
u
n
e
cocktail
compos
l
b
u
l
p
b
g
b
e
c
k
n
n
r
u
e
l
water
l
n
toluen
use
b
e
c
k
n
liquid
scintil
counter
h
e
p
e
k
fraction
pool
n
h
e
viru
pellet
two
h
u
r
b
e
c
k
n
f
rotor
r
p
h
e
viru
pellet
r
c
u
p
e
n
e
drop
sodium
p
h
p
h
e
buffer
pool
n
either
use
e
e
l
store
c
viru
r
n
p
e
r
f
r
e
b
h
e
n
r
plaqu
assay
monolay
cell
cm
dispos
cultur
flask
lux
scientif
corpor
describ
previous
f
r
p
l
q
u
e
e
v
e
l
p
e
n
e
n
c
u
b
n
day
n
polio
two
day
viru
titr
express
plaqueform
unit
per
ml
p
f
u
l
e
e
r
n
e
h
e
p
e
r
c
e
n
g
e
p
e
r
e
n
l
infect
cell
releas
infecti
viru
n
l
e
r
l
ceil
hv
wash
rypsin
n
p
p
r
p
r
e
dilut
h
e
cell
l
n
e
n
n
c
e
e
u
e
confluent
u
n
n
f
e
c
e
l
monolay
w
h
w
h
u
p
r
e
r
e
e
n
w
h
n
e
guinea
pig
serum
two
h
r
e
e
hour
c
allow
h
e
cell
settl
n
c
h
h
e
layer
h
e
n
l
e
r
cover
w
h
overlay
e
u
n
plaqu
allow
develop
day
c
n
e
r
u
g
n
purifi
n
c
n
c
e
n
r
e
e
viru
n
g
e
n
p
r
e
p
r
e
male
g
u
n
e
pig
iiartleyalbino
u
b
r
e
e
weigh
g
accord
h
e
follow
schedul
day
ml
n
g
e
n
h
e
f
p
day
rnl
n
g
e
n
w
h
complet
f
r
e
u
n
j
u
v
n
gibco
u
b
c
u
n
e
u
l
n
day
ml
n
g
e
n
j
u
v
n
n
r
u
c
u
l
r
l
h
e
n
l
bled
b
h
e
r
p
u
n
c
u
r
e
prior
u
n
z
n
control
n
weekli
h
r
u
g
h
u
procedur
viru
neut
r
l
z
n
titr
b
n
e
b
n
r
plaqu
r
e
u
c
n
assay
tenfold
serial
dilut
guinea
pig
n
e
serum
p
r
e
p
r
e
salin
l
x
e
equal
u
n
w
h
suspens
e
e
l
vii
virus
dilut
p
p
r
p
r
e
l
give
b
e
w
e
e
n
n
p
f
u
l
l
salin
w
h
u
n
e
r
u
e
parallel
serv
viru
control
one
h
u
r
room
e
p
e
r
u
r
e
l
sampl
seed
duplic
onto
l
monolay
allow
r
b
one
hour
cover
w
h
overlay
e
u
n
h
e
plaqu
allow
develop
day
c
e
n
p
n
calcul
h
e
basi
p
e
r
cent
r
e
u
c
n
p
l
q
u
e
format
prepar
neg
stain
sodium
potassium
phosphotungst
per
cent
follow
standard
procedur
describ
previous
grid
made
directli
gradient
fraction
sucros
commonli
fraction
dilut
sodium
phosphat
buffer
centrifug
g
hour
iesult
pellet
resuspend
distil
water
grid
prepar
immedi
grid
examin
philip
electron
microscop
assay
revers
transeriptas
rt
activ
carri
courtesi
dr
greig
anim
diseas
eseareh
institut
agricultur
canada
ottawa
use
kit
mammalian
viral
revers
transcriptas
collabor
research
inc
waltham
mass
follow
recommend
procedur
kit
design
distinguish
enzym
dna
polymeras
activ
e
coli
poiymeras
activ
provid
templat
includ
intern
control
test
perform
supernat
fluid
uninfect
persist
infect
l
cell
pellet
resuspend
test
viral
rt
activ
use
primer
templat
provid
oligo
dt
poli
ra
posit
neg
control
supernat
fluid
bovin
leukemia
viru
infect
fetal
lamb
kidney
cell
uninfect
fetal
lamb
spleen
cell
respect
cation
requir
mg
mn
enzym
assess
test
monolay
l
cell
infect
stock
viru
multipl
moi
cm
tissu
cultur
flask
adsorpt
room
temperatur
one
hour
n
e
n
n
c
e
e
u
growth
medium
mem
ad
flask
incub
either
c
hour
medium
decant
layer
rins
phosphat
buffer
salin
pb
depend
integr
monolay
cell
either
trypsin
n
reseed
fresh
flask
overlaid
fresh
growth
medium
cell
layer
monitor
daili
growth
medium
chang
daili
cell
passag
layer
approach
confluenc
becam
clear
h
monotuy
grow
satisfactorili
approxim
week
atiquot
e
u
collect
nd
assay
infecti
viru
plaqu
titrat
success
n
e
n
n
c
e
persist
infect
cell
cultur
directli
relat
n
c
u
b
n
temperatur
cultur
subsequ
initi
infect
viru
distinct
visual
differ
cell
monolay
could
correl
viru
n
p
u
multipl
b
u
infect
cultur
kept
c
fare
well
c
therefor
effect
temperatur
mainten
examin
temperatur
chosen
c
optim
replic
c
optimum
l
cell
growth
cultur
kept
c
supraoptim
viru
replic
initi
incub
viru
chang
c
shortli
hour
incub
c
surviv
infect
form
stabl
popul
cell
appear
normal
grew
rate
characteristi
l
cell
cultur
contrast
cell
infect
maintain
c
throughout
chang
cours
experi
grew
slowli
irregularli
never
reach
confluent
monolay
week
mainten
c
cell
continu
shed
viru
medium
progress
decreas
amount
log
less
termin
furthermor
severm
week
cell
recov
return
incub
temperatur
c
comparison
control
uninfect
l
cultur
grew
slowli
c
c
appear
normal
resum
normal
growth
rate
return
optim
incub
temperatur
c
stabl
persist
infect
cell
maintain
c
store
c
month
reviv
advers
effect
still
grow
characterist
shed
viru
distinguish
cell
viru
standard
system
cell
term
iiv
viru
deriv
cultur
vh
sever
subsequ
attempt
made
establish
new
e
persist
infect
cell
line
new
long
term
stabl
virusshed
popul
obtain
success
outcom
attempt
could
predict
work
aim
defin
critic
procedur
consist
product
persist
infect
progress
sinc
time
initi
infect
viru
strict
precaut
taken
ensur
viru
reintroduc
time
write
persist
infect
cell
passag
time
split
schedul
uninfect
l
cell
everi
two
day
month
continu
shed
high
titr
viru
pfuml
repres
virionscel
show
appar
deleteri
effect
visual
differ
l
hv
cell
layer
appar
first
day
passag
confluent
monolay
reach
consist
iiv
cultur
show
pattern
cell
growth
distinguish
l
cell
cultur
initi
growth
individu
cell
persist
infect
hv
cultur
show
characterist
elong
spread
seen
uninfect
l
cell
fig
b
confluent
howev
monolay
visual
ident
fig
c
sinc
number
cell
hour
confluent
monolay
uninfect
persist
infect
cell
equival
fig
characterist
pattern
probabl
reflect
presenc
replic
viru
infecti
center
assay
determin
number
infect
cell
hv
cultur
tent
indic
percent
produc
viru
hv
cell
clone
result
cultur
viru
produ
andor
resist
snperinfect
viru
result
need
confirm
immunofluores
method
throughout
studi
quantiti
infecti
viru
shed
cultur
medium
mt
per
em
flask
routin
determin
weekli
interv
interv
amount
cell
associ
viru
also
measur
consist
reveal
five
ten
time
greater
amount
viru
basi
total
yield
viruscel
two
day
growth
period
ie
one
cell
passag
product
viru
correl
directli
increas
number
cell
fig
show
fold
increas
hour
period
cell
viru
product
n
persist
system
monolay
retain
integr
agar
c
c
seven
day
result
neutral
test
perform
e
serum
indic
h
persist
viru
fact
coronaviru
serum
equal
effect
neutral
v
h
virus
percent
plaqu
reduct
endpoint
kinet
neutral
evalu
morpholog
type
coronavirus
compar
examin
neg
stain
prepar
electron
microscop
relev
differ
could
seen
persist
shed
virion
virion
despit
lack
eytopath
effect
persist
infect
cultur
isol
v
viru
seem
eytocidat
h
n
stock
e
viru
w
h
e
n
acut
v
viru
infect
l
cell
carri
liquid
medium
gener
addit
tile
txl
sampl
reaction
mixtur
contain
mm
tri
ttci
cell
deterior
cpe
evid
hour
earlier
standard
e
viru
infect
similar
condit
furthermor
onestep
growth
curv
experi
virus
show
replic
v
h
viru
consist
earlier
reach
higher
titr
standard
viru
fig
increas
replic
effici
v
h
viru
indic
earlier
develop
day
clearer
slightli
larger
plaqu
compar
viru
fig
sampl
titrat
duplic
plaqu
assay
titr
express
log
pfuml
vii
viru
label
uridin
acid
vh
viru
isol
label
also
uridin
acid
acut
infect
l
cell
harvest
purifi
compar
standard
e
viru
similarli
prepar
densiti
viru
determin
isopyen
sucros
gradient
analysi
e
v
h
viru
gmce
fig
lzixza
isol
virus
isokineti
sucros
gradient
gave
profil
singl
larg
molecular
weight
speci
r
n
data
shown
viral
yield
lyric
infect
carri
c
alway
log
higher
v
h
virus
tabl
mechan
persist
cell
appear
involv
either
interferon
product
integr
defect
interf
particl
assay
revers
transeriptas
l
cell
persist
infect
cell
measur
presenc
mg
mn
neg
tabl
interferon
assay
plaqu
reduct
method
detect
normal
acut
infect
persist
infect
cell
data
shown
interfer
defect
interf
particl
di
could
complet
rule
b
u
effort
detect
particl
unsuccess
date
vh
viru
could
distinguish
standard
stock
viru
n
method
tfi
ie
densiti
fig
tabl
also
faet
h
viru
titr
h
v
cell
vari
cours
year
suggest
h
particl
unlik
involv
e
p
e
r
u
r
e
sensit
therefor
promis
avenu
investig
sinc
persist
state
show
e
p
e
r
u
r
e
depend
persist
infect
cell
cultur
success
n
n
e
c
c
optim
e
p
e
r
u
r
e
e
viru
replic
c
initi
persist
infect
abort
sever
week
n
sever
e
p
chang
h
v
cultur
c
met
gradual
deterior
eventu
halt
growth
loss
integr
layer
howev
accompani
b
increas
viru
shed
f
u
r
h
e
r
r
e
plaqu
effici
virus
percent
lower
c
compar
c
fact
indic
emerg
e
p
e
r
u
r
e
sensit
u
n
per
se
b
u
r
h
e
r
impli
contribut
host
cell
e
p
e
r
u
r
e
depend
vitro
virushost
system
describ
appear
first
report
instanc
h
u
n
coronaviru
hcv
e
give
rise
persist
infect
cell
cultur
infect
e
initi
j
u
e
n
period
persist
infect
cell
hv
cell
continu
subcultur
shed
viru
e
u
high
titr
h
n
two
year
preliminari
experi
suggest
h
j
r
h
v
cell
infect
n
vitro
persist
infect
sever
differ
mechan
propos
includ
suppress
viru
product
b
interferon
interter
b
defect
interf
di
particl
integr
viral
genom
genet
u
n
viru
system
report
first
three
mechan
seem
play
role
neither
interferon
revers
transcriptas
activ
detect
di
particl
seem
involv
sinc
signific
chang
viru
shed
passag
persist
infect
cell
cultur
biochem
morphologicm
evid
two
tpe
particl
also
interfer
could
demonstr
mix
infect
vh
viru
howev
experi
necessari
provid
suffici
evid
exclud
involv
di
particl
common
factor
severm
vitro
persist
virushost
system
product
temperatur
sensit
viru
progeni
exampl
mutant
isol
persist
infect
measl
newcastl
diseas
viru
vesicular
stemat
viru
mump
viru
among
coronavirus
mous
hepat
viru
report
develop
persist
infect
vitro
temperatur
sensit
mutant
mhv
k
holm
abstract
int
l
virol
iv
cold
sensit
mutant
jhm
neurotrop
strain
mttv
isol
lvca
et
al
describ
temperatur
associ
vitro
persist
mous
hepat
viru
found
viral
replic
thermosensit
cell
cultur
persist
infect
strain
jhm
although
viru
progeni
persist
infect
thermolabil
hv
system
temperatur
effect
associ
establish
mainten
persist
howev
experi
requir
determin
role
temperatur
virushost
system
sinc
viru
isol
persist
infect
cell
hv
caus
pronounc
cpe
e
viru
l
cell
seem
probabl
chang
occur
viru
host
cell
earli
stage
establish
persist
experi
progress
elucid
tile
mechan
mechan
involv
establish
mainten
persist
human
eoronaviru
vitro
